Takotsubo Syndrome: Cardiotoxic Stress in the COVID Era
View Full Paper
Ask AI
Bookmark
Share
Key result
The incidence of Takotsubo syndrome rose 4.5-fold during the COVID-19 pandemic, presumably caused by increased emotional stress rather than direct viral infection.
Why the study?
The incidence of Takotsubo syndrome rose during the COVID-19 pandemic, prompting an update on its underlying mechanisms, diagnosis, and optimal management.
Structured PICO
P
Population
Patients with Takotsubo syndrome (TTS) and stress cardiomyopathy
Takotsubo syndrome is a stress-mediated cardiomyopathy with a prognosis similar to acute coronary syndrome, and its incidence increased 4.5-fold during the COVID-19 pandemic.
Limitations
- Lack of randomized controlled trials defining optimal therapy for Takotsubo syndrome
- True global burden remains uncertain due to lack of physician awareness, difficulty in diagnosis, and resemblance to acute coronary syndrome
Authors
Discussion
No takes yet. Share an insight, caveat, or question.
Implication
TTS as dramatic psychosomatic neurocardiac entity; extends recognition of stress cardiomyopathy for targeted diagnostic and mechanistic research.
Cite This Study
O’Keefe et al. (2020) conducted a review in Takotsubo syndrome. COVID-19 pandemic vs. Pre-pandemic period was evaluated. The incidence of Takotsubo syndrome rose 4.5-fold during the COVID-19 pandemic, presumably caused by increased emotional stress rather than direct viral infection.
View Full Paper
Ask AI
Bookmark
Share